Can the Chairman's share purchase at One Ray of Sunshine (02522.HK) boost market confidence?

ZC Asia has learnt that following several days of abnormal share price declines, One Pulse Sunshine (02522.HK) issued consecutive announcements on 8th and 9th December, emphasising normal daily operations and announcing a share repurchase plan capped at HK$200 million. Chairman Chen Chaoyang also increased his holdings by 59,500 shares at HK$10.10 per share.

(Image source: Snowball)

 These measures have temporarily bolstered market confidence, yet the company's financial position reveals deeper underlying challenges.

Operational Strategy and Capital Market Misalignment

A detailed examination of the company's mid-2025 balance sheet reveals pressure accompanying its expansion through shifts in several key items.

Structural shifts in assets are pronounced: property, plant and equipment decreased by 6.5% year-on-year, while intangible assets surged by 162.64%. This dual trend reflects the company's transition from heavy to light asset models.

Concurrently, trade receivables rose significantly by 19.83% to RMB570 million. This typically indicates extended payment terms granted to partners during business expansion, potentially compromising cash flow health.

Liability pressures are more immediate. Short-term borrowings and lease liabilities reached RMB 189 million, while cash and bank balances stood at RMB 365 million. Though sufficient to cover short-term debt, liquidity management remains critical in this capital-intensive sector.

The Tug-of-War Between Technological Transformation and Profitability

As an industry leader, Yimuyangguang's core challenge lies in its failure to effectively translate scale advantages into profitability.

The US market offers instructive parallels: sector leader RadNet operates 357 imaging centres yet achieves a net profit margin of merely 2.35%. This demonstrates that even in mature markets, inherent characteristics such as high fragmentation, capital-intensive operations, and costly equipment inherently constrain profitability in this sector.

To overcome this bottleneck, Yimayang is actively pursuing its strategic direction in ‘medical cloud imaging’. Policy support also favours this transformation. The 2025 China Medical Cloud Imaging Industry White Paper indicates the sector is entering a golden development period with multiple favourable factors converging, projecting the market size to exceed RMB 10 billion by 2027.

Yet, there remains a gap between aspiration and reality. The company's flagship ‘Yimay Cloud Service’, regarded as its cornerstone, contributed merely 6.523 million yuan in revenue during the first half of 2025, accounting for a mere 1.4% of total revenue, proving insufficient to become a performance pillar.

Risks of Single-Region and Core Business Dependency

Yimay Sunshine's operational risks are further amplified by its highly concentrated regional distribution.

The company's business is geographically reliant on Jiangxi Province, which contributed 55.59% of total revenue in 2023. This dependency magnifies operational risks when confronted with regional economic fluctuations or policy changes.

In terms of business composition, the fastest-growing segment is the ‘trade-oriented’ business with relatively low gross margins. During the first half of 2025, the ‘imaging equipment solutions’ service – assisting hospitals in procuring imaging equipment – generated 32.55% of total revenue, becoming the second-largest income stream.

While such equipment-focused trading operations enable rapid scale expansion, they exhibit limited growth sustainability and low technological barriers, diverging from the company's long-term strategic positioning as a ‘medical data and artificial intelligence’ technology service provider.

Deploying medical imaging equipment worth hundreds of millions of yuan into hospitals generates transaction volumes and facilitates device connectivity. However, transforming these hardware assets and networks into sustainable, high-margin digital services represents a critical hurdle OneRay must overcome before reaching its profitability inflection point.

Disclaimer: The content herein is for reference only and does not constitute any form of investment advice. Should any information contained herein prove inaccurate, incomplete, or potentially misleading, please refer to the company's official announcements. Market risks exist; investment requires caution.